ARVINAS, INC. Interest Income (Expense), Net
ARVINAS, INC. (ARVN) reported Interest Income (Expense), Net of $3.40 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2022-11-09
- ARVINAS, INC. interest income (expense), net for the quarter ending 2022-09-30 was $3.40M, a 1033.33% increase year-over-year.
- ARVINAS, INC. interest income (expense), net for the quarter ending 2022-06-30 was $1.80M, a 350.00% increase year-over-year.
- ARVINAS, INC. interest income (expense), net for the quarter ending 2022-03-31 was $1.20M, a 140.00% increase year-over-year.
- ARVINAS, INC. interest income (expense), net for the quarter ending 2021-09-30 was $300.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month |
|---|---|---|---|
| 2022-09-30 | $3.40M 10-Q · filed 2022-11-09 | $5.20M derived: sum of 2 quarters · filed 2022-11-09 | $6.30M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.80M 10-Q · filed 2022-08-04 | $2.90M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.20M 10-Q · filed 2022-05-05 | ||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-09 | $700.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.20M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $400.00K 10-Q · filed 2022-08-04 | $800.00K 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $500.00K 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |